Australia, Jan. 7 -- Principia Biopharma Inc., owns the trademark (2549176) for 'CENRIFKI' and 'SEMI-CIRCLE & QUADRANT,INTERLOCKING' till May 20, 2035.
Status: registered:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of multiple sclerosis.]
Type of Mark: Figurative
Date of Acceptance: June 24, 2025
Registration Advertised: Jan. 6
For further details contact Spruson & Ferguson.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2549176.
Disclaimer: Curated by HT Syndication.
